Israeli Startup Ayala Taking BMS Cancer Drug Into Phase II With $17m Financing

 
• By Lucie Ellis-Taitt
  
Israeli Flag in Jerusalem, israel
Emerging Israeli biopharma flies flag for ex-BMS cancer therapy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas